Interestingly, although tumor size decreased in the palbociclib group, CCND1 expression was slightly higher than in the control group (Fig. 8K), further supporting the notion that increased CCND1 expression may contribute to palbociclib resistance. This evidence concerns the gene CCND1 and neoplasm.